glp1 liraglutide cardiovascular disease in patients with type 2 diabetesor111
26:43 Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'
Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'
26:43
2 161 просмотр
7:17 Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes
Cardiovascular Outcomes With GLP-1 Receptor Agonists in Type 2 Diabetes
7:17
1 799 просмотров
1:33:23 GLP-1 ( Liraglutide )&Cardiovascular Disease in Patients with Type 2 Diabetes,Organized by ICC, 2020
GLP-1 ( Liraglutide )&Cardiovascular Disease in Patients with Type 2 Diabetes,Organized by ICC, 2020
1:33:23
937 просмотров
3:38 The use of GLP-1 receptor agonists for reducing cardiovascular risk on type-2 diabetes patients
The use of GLP-1 receptor agonists for reducing cardiovascular risk on type-2 diabetes patients
3:38
137 просмотров
9:24 GLP-1 Agonists in T2D: Cardiovascular Outcomes Data
GLP-1 Agonists in T2D: Cardiovascular Outcomes Data
9:24
1 423 просмотра
3:50 Diabetes Drugs for Cardiovascular Risk
Diabetes Drugs for Cardiovascular Risk
3:50
855 просмотров
13:54 Using GLP1 receptor agonists to treat cardiac patients with diabetes
Using GLP1 receptor agonists to treat cardiac patients with diabetes
13:54
8 534 просмотра
32:30 Reducing Cardiometabolic Risks and Achieving Glycemic Targets With GLP-1 RAs
Reducing Cardiometabolic Risks and Achieving Glycemic Targets With GLP-1 RAs
32:30
912 просмотров
2:09 Cardiovascular Outcomes in Patients with Diabetes
Cardiovascular Outcomes in Patients with Diabetes
2:09
3 549 просмотров
3:54 Cardiovascular disease treatment, Liraglutide, and modifying diabetes risk factors
Cardiovascular disease treatment, Liraglutide, and modifying diabetes risk factors
3:54
225 просмотров
4:46 Understanding Cardiovascular Benefit With the LEADER Trial
Understanding Cardiovascular Benefit With the LEADER Trial
4:46
1 706 просмотров
2:09 Is One SGLT2 (Or GLP-1) Just Like Another for Cardiac Benefit?
Is One SGLT2 (Or GLP-1) Just Like Another for Cardiac Benefit?
2:09
832 просмотра
5:37 Liraglutide can maintain Glycemic Control In the Patients With Type 2 Diabetes Mellitus
Liraglutide can maintain Glycemic Control In the Patients With Type 2 Diabetes Mellitus
5:37
234 просмотра
14:53 Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
Fundamentals of SGLT2i's and GLP-1RA's for CV Risk
14:53
1 577 просмотров
1:51 Liraglutide and Cardiovascular Outcomes
Liraglutide and Cardiovascular Outcomes
1:51
23 234 просмотра
1:54 Semaglutide and Cardiovascular Risks
Semaglutide and Cardiovascular Risks
1:54
29 952 просмотра
1:31 Liraglutide Lowers Cardiovascular Outcomes in Type 2 Diabetes
Liraglutide Lowers Cardiovascular Outcomes in Type 2 Diabetes
1:31
204 просмотра
7:37 #Liraglutide | Uses, Dosage, Side Effects & Mechanism | Victoza
#Liraglutide | Uses, Dosage, Side Effects & Mechanism | Victoza
7:37
160 просмотров
3:38 Evaluation of Efpeglenatide on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes
Evaluation of Efpeglenatide on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes
3:38
103 просмотра
39:16 Cardioprotective Effects of Newer Antidiabetes Medications, February 21, 2020
Cardioprotective Effects of Newer Antidiabetes Medications, February 21, 2020
39:16
781 просмотр